Diabetes Treatment Semaglutide Helps Obese Patients Lose Weight

Type-2 Diabetes is one of the most significant health risks in the United States, affecting millions of Americans over the age of forty. Obesity is one of the monumental risk factors for Type-2 Diabetes and is an epidemic in the country. By 2018, over 40% of Americans are categorized as obese, with over 9% considered severely obese.

Semaglutide Effective Drug to treat Type-2 Diabetes—Could It Be More?

Semaglutide was FDA-Approved for the treatment of Diabetes in 2017, and researchers are still working to increase our knowledge regarding the beneficial impacts of the treatment. Many patients without Diabetes may also benefit from Semaglutide.

While Semaglutide has proven useful at helping Type-2 Diabetes patients lose weight and improve Insulin Sensitivity, scientists also believe the medication may be helpful in the treatment of obesity even without diagnosed Diabetes. Recent Clinical Trials have sought to explore how Semaglutide helps obese patients lose weight in combination with a diet and exercise program.

Phase 3 Semaglutide Obesity Trial Shows Great Promise

The results of Phase 3 of this trial were recently printed in The New England Journal of Medicine. In the end, patients taking Semaglutide experienced a reduction of body weight averaging 14.9 percent after following injection and lifestyle protocols. Almost all patients experienced significant weight loss in this study. Half of the experimental group lost at least 15% body weight, and 86% lost at least 5%.

Aside from these excellent weight loss results, the patients were also determined to be less threatened by the risk of heart disease and diabetes. They also reported improved exercise output and heightened physical function.

If Semaglutide could help patients lose weight without risks that outweigh the benefits, it could be a boon for hundreds of millions of people worldwide. Obesity is one of the biggest risk factors for several dangerous conditions such as cancer, fatty liver disease, Type-2 Diabetes, and heart disease.

It also contributes heavily to forms of Hormone Imbalance such as Human Growth Hormone Deficiency and Low-T. As you can imagine, this huge collection of risks has a tremendous effect on average life expectancy for men and women struggling with obesity.

As of today, exercise and diet are the primary means to help patients overcome obesity. Medications are generally only offered after six months of ineffective efforts. While medications can aid patients in losing weight, they come with their own risks and drawbacks. There is some hope that Semaglutide could be safer than most other Obesity Treatments on the market today.

How Does Semaglutide Work?

Semaglutide is a form of Hormone Therapy. It's designed to perfectly simulate the function of the naturally occurring hormone GLP-1. This hormone is released by the digestive system after eating, and it helps to control satiety and reduce cravings and hunger.

The treatment had relatively few side effects. Around 4.5% of experimental patients quit the treatment resulting from gastrointestinal issues, most commonly diarrhea and nausea. Most patients that experienced these side-effects dealt with them only temporarily.

Contact Us For HGH And Sermorelin Injection Treatment

Name (*)
Email (*)
Phone (*)
Select A Program (*)	HGH InjectionsTestosterone InjectionsCo-Created ProgramTestosterone TherapyAt Home HRT ProgramSermorelin InjectionsIpamorelinPeptidesWeight ManagementHuman Growth HormoneShort Height TherapyGender Dysmorphia
Select US State (*)	Select Your StateAlabamaAlaskaArizonaArkansasCaliforniaCanadaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahU.S. Virgin IslandsVermontVirginiaWashingtonWashington,DCWest VirginiaWisconsinWyomingCanada
Select Age (30+ only)	30313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120
Confirm over 30 years old (*)	Yes
Confirm living in the USA? (*)	Yes

List of USA state clinics - click a flag below for blood testing clinics.

Alabama Hormone Blood Analysis	Alaska Hormone Blood Analysis
Arizona Hormone Blood Analysis	Arkansas Hormone Blood Analysis
California Hormone Blood Analysis	Colorado Hormone Blood Analysis
Connecticut Hormone Blood Analysis	Delaware Hormone Blood Analysis
Florida Hormone Blood Analysis	Georgia Hormone Blood Analysis
Hawaii Hormone Blood Analysis	Idaho Hormone Blood Analysis
Illinois Hormone Blood Analysis	Indiana Hormone Blood Analysis
Iowa Hormone Blood Analysis	Kansas Hormone Blood Analysis
Kentucky Hormone Blood Analysis	Louisiana Hormone Blood Analysis
Maine Hormone Blood Analysis	Maryland Hormone Blood Analysis
Massachusetts Hormone Blood Analysis	Michigan Hormone Blood Analysis
Minnesota Hormone Blood Analysis	Mississippi Hormone Blood Analysis
Missouri Hormone Blood Analysis	Montana Hormone Blood Analysis
Nebraska Hormone Blood Analysis	Nevada Hormone Blood Analysis
New Hampshire Hormone Blood Analysis	New Jersey Hormone Blood Analysis
New Mexico Hormone Blood Analysis	New York Hormone Blood Analysis
North Carolina Hormone Blood Analysis	North Dakota Hormone Blood Analysis
Ohio Hormone Blood Analysis	Oklahoma Hormone Blood Analysis
Oregon Hormone Blood Analysis	Pennsylvania Hormone Blood Analysis
Rhode Island Hormone Blood Analysis	South Carolina Hormone Blood Analysis
South Dakota Hormone Blood Analysis	Tennessee Hormone Blood Analysis
Texas Hormone Blood Analysis	Utah Hormone Blood Analysis
Vermont Hormone Blood Analysis	Virginia Hormone Blood Analysis
Washington Hormone Blood Analysis	Washington, D.C. Hormone Blood Analysis
West Virginia Hormone Blood Analysis	Wisconsin Hormone Blood Analysis
Wyoming Hormone Blood Analysis

Word Count: 495